Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Work-Related Violent Deaths in the US Taxi and Limousine Industry 2003 to 2013
  • Published Date:
    Aug 2017
  • Source:
    J Occup Environ Med. 59(8):768-774.
Filetype[PDF-439.57 KB]


Details:
  • Alternative Title:
    J Occup Environ Med
  • Personal Author:
  • Description:
    Objective We describe the magnitude and distribution of violent work-related deaths among taxi and limousine drivers, a high-risk population. Methods We analyzed rates using the Bureau of Labor Statistics Census of Fatal Occupational Injuries (CFOI) for all violent work-related deaths in the taxi and limousine industry from 2003 to 2013. We described demographics, work characteristics, and other injury details, examining temporal trends for nativity and race/ethnicity. Results Men (adjusted rate ratio [RRadj] 6.1 [95% confidence interval [CI] 2.6–14.1]), blacks (RRadj 2.3 [95% CI 1.6–3.4]), Hispanics (RRadj 2.1 [95% CI 1.3–3.4]), and drivers in the South (RRadj 2.7 [95% CI 1.9–3.9]) had significantly higher fatality rates than comparison groups. Over time, the rates remained substantially higher compared with all workers. Conclusions The taxi and limousine industry continues to face a disproportionately dangerous working environment. Recommended safety measures implemented uniformly by cities, companies, and drivers could mitigate disparities.
  • Subject:
  • Pubmed ID:
    28665838
  • Pubmed Central ID:
    PMC5576347
  • Document Type:
    Journal Article
  • Funding:
    CC999999/Intramural CDC HHS/United States
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
No Related Documents.
You May Also Like:
  1. CMS and CDC announce provider reimbursement available for counseling patients to self-isolate at time of COVID-19 testing : press release : for immediate release: Thursday, July 30, 2020
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Centers for Medicare & Medicaid Services (U.S.).
    Published Date:
    July 30, 2020
    Description:
    Today, the Centers for Medicare and Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC) are announcing that payment is available to physicians and health care providers to counsel patients, at the time of coronavirus dise...
    File Type:
    Filetype[PDF - 69.22 KB]
  2. How to report COVID-19 laboratory data
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    July 29, 2020
    Series:
    Coronavirus Disease 2020 (COVID-19)
    Description:
    Updated July 29, 2020The public health response to COVID-19 depends on comprehensive laboratory testing data. These data will contribute to understanding disease incidence and testing coverage, and can contribute to the identification of supply chain...
    File Type:
    Filetype[PDF - 173.37 KB]
  3. Coronavirus Disease 2019 (COVID-19) hospitalizations forecasts
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    July 29, 2020
    Series:
    Coronavirus Disease 2020 (COVID-19)
    Description:
    Updated July 29, 2020Interpretation of Forecasts of New Hospitalizations• This week, five national forecasts predict a likely increase in the number of new hospitalizations per day over the next four weeks, one forecast predicts a likely decline, a...
    File Type:
    Filetype[PDF - 285.98 KB]
  4. Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    July 28, 2020
    Description:
    Updated July 28, 2020Updates to the list of underlying medical conditions that put individuals at increased risk for severe illness from COVID-19 were based on published reports, articles in press, unreviewed pre-prints, and internal data available b...
    File Type:
    Filetype[PDF - 112.68 KB]
  5. U.S. clinical laboratories reporting SARS-CoV-2 test results to CDC : updated July 24, 2020
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    July 24, 2020
    Series:
    COVIDView
    Description:
    U.S. Clinical Laboratories Reporting SARS-CoV-2 Test Results to CDCMarch 8, 2020 – July 18, 2020Data as of July 23, 2020
    File Type:
    Filetype[PDF - 345.27 KB]